Tubeless Insulin Pump Market Report 2025

The tubeless insulin pump market size has grown rapidly in recent years. It will grow from $1.84 billion in 2024 to $2.2 billion in 2025 at a compound annual growth rate (CAGR) of 19.5%. The growth in the historic period can be credited to the increasing prevalence of diabetes, rising demand for convenient and discreet insulin delivery methods, growing awareness about diabetes management, enhanced reimbursement policies, patient preference for pain-free insulin administration, and the expansion of home healthcare solutions.

The tubeless insulin pump market size is expected to see rapid growth in the next few years. It will grow to $4.44 billion in 2029 at a compound annual growth rate (CAGR) of 19.1%. The growth in the forecast period can be attributed to rising demand for discreet and user-friendly insulin delivery systems, increased focus on personalized diabetes management, expansion of reimbursement policies for advanced insulin devices, and growing awareness through digital health initiatives. Major trends in the forecast period include the integration of AI-powered glucose monitoring, enhanced smartphone app connectivity, miniaturization of patch devices, adoption of closed-loop systems, and wider use of wearable health technologies.

The rising prevalence of diabetes is expected to drive the growth of the tubeless insulin pump market in the coming years. Diabetes is a chronic condition characterized by high blood sugar due to the body’s inability to produce or effectively use insulin. The increase in diabetes cases is largely linked to rising obesity rates, which are strongly associated with poor diet and physical inactivity. Tubeless insulin pumps help manage diabetes by delivering continuous, controlled doses of insulin without the need for multiple daily injections, effectively regulating blood sugar levels. For example, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people worldwide were living with diabetes. This number is projected to more than double, reaching 1.3 billion by 2050. Consequently, the growing prevalence of diabetes is fueling demand for tubeless insulin pumps.

Key players in the tubeless insulin pump market are focusing on developing advanced solutions, such as basal-only insulin pods, to provide simplified and cost-effective insulin delivery for individuals with type 2 diabetes who require only background insulin support. A basal-only insulin pod is a wearable pump that delivers a continuous background dose of insulin to help control blood sugar levels, primarily for those with type 2 diabetes. In April 2023, Insulet Corporation, a US-based medical device company, launched Omnipod GO, an insulin delivery device approved for use in adults with type 2 diabetes who would normally receive daily long-acting insulin injections. Omnipod GO is a wearable, independent device that delivers a constant rate of rapid-acting insulin for 72 hours. The tubeless and waterproof pod comes in seven pre-programmed daily rates ranging from 10 to 40 units and operates without the need for a mobile device.

In January 2023, Tandem Diabetes Care, a US-based insulin delivery and diabetes technology company, acquired AMF Medical SA for an undisclosed amount. This acquisition supports Tandem’s sustainability initiatives by reducing battery waste through the Sigi pump’s rechargeable design while expanding its portfolio of advanced insulin delivery solutions. AMF Medical SA, based in Switzerland, specializes in the manufacture of reusable patch (tubeless) insulin pumps.

Major players in the tubeless insulin pump market are F. Hoffmann-La Roche AG, Sanofi SA, Abbott Laboratories, Medtronic plc, Eli Lilly and Company, Becton Dickinson & Company, Fresenius Kabi AG, Terumo Corporation, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed AG, Ascensia Diabetes Care, MicroTech Medical, Menarini Diagnostics, Bigfoot Biomedical, Debiotech SA, Medtrum Technologies Inc., Diabeloop, SOOIL Development, and Beta Bionics.

North America was the largest region in the tubeless insulin pump market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tubeless insulin pump market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the tubeless insulin pump market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

A tubeless insulin pump is a wearable medical device designed for people with diabetes to provide continuous insulin delivery without the use of external tubing. It adheres directly to the skin and communicates wirelessly with a handheld controller, offering a more convenient and discreet method of insulin administration.

The primary types of tubeless insulin pumps include wearable and implantable insulin pumps. Wearable pumps are compact devices worn on the body that administer continuous doses of short-acting insulin subcutaneously, minimizing the need for multiple daily injections. These pumps utilize technologies such as continuous glucose monitoring (CGM), integrated pump systems, and standard tubeless pumps, and are utilized by end users including hospitals, pharmacies, e-commerce platforms, and others.

The tubeless insulin pump market research report is one of a series of new reports that provides tubeless insulin pump market statistics, including the tubeless insulin pump industry global market size, regional shares, competitors with the tubeless insulin pump market share, detailed tubeless insulin pump market segments, market trends, and opportunities, and any further data you may need to thrive in the tubeless insulin pump industry. This tubeless insulin pump market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tubeless insulin pump market consists of sales of infusion sets, insertion tools, adhesives pods, and handheld or smartphone-based controllers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.